JAGSNPHARM — Jagsonpal Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Jagsonpal Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2020 March 31st	R2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	Interim Report	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	408	637	471	1,146	1,480
Net Total Accounts Receivable
Net Total Receivables	218	127	156	249	110
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	963	1,186	1,091	1,646	1,993
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	240	233	226	243	93
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,487	1,648	1,642	1,949	2,171
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	346	370	270	276	191
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	377	390	315	361	297
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	1,110	1,258	1,328	1,589	1,874
Total Liabilities & Shareholders' Equity	1,487	1,648	1,642	1,949	2,171
Total Common Shares Outstanding